MPM Oncology Impact Management GP LLC's Net Worth
$0
Who is MPM Oncology Impact Management GP LLC?
MPM Oncology Impact Management GP LLC does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Werewolf Therapeutics, Inc., iTeos Therapeutics, Inc., Spring Bank Pharmaceuticals, Inc., Harpoon Therapeutics, Inc., TCR2 THERAPEUTICS INC., SUNESIS PHARMACEUTICALS INC, Oncorus, Inc., and Cullinan Management, Inc..
SEC CIK
MPM Oncology Impact Management GP LLC's CIK is 0001721035
Past Insider Trading and Trends
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
iTeos Therapeutics, Inc. (ITOS) Snapshot price: $14.8
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -0.00% | -200.00 |
$29.99 | -$5,998.00 | 6M |
Scheduled
|
Apr 9
| ||
Form 4
| -0.95% | -57.65K |
$30.99 | -$1,300,850.41 | 6M |
Scheduled
|
Apr 7 - Apr 8
| ||
Form 4
| +64.51% | 6.06M |
$19.00 | $6,080,000.00 | 15.46M |
Jul 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Werewolf Therapeutics, Inc. (HOWL) Snapshot price: $2.03
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +1,346.05% | 6.21M |
$16.00 |
—
| 6.67M |
May 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Harpoon Therapeutics, Inc. (HARP) No price found
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -0.90% | -57.49K |
$20.63 | -$1,186,189.84 | 6.33M |
Scheduled
|
May 28 - Jun 2
| ||
Form 4
| -0.27% | -17.16K |
$20.22 | -$346,937.78 | 6.39M |
Scheduled
|
May 26 - May 27
| ||
Form 4
| -0.25% | -15.91K |
$20.18 | -$321,030.47 | 6.4M |
Scheduled
|
May 21 - May 24
| ||
Form 4
| -0.74% | -47.95K |
$20.49 | -$982,226.63 | 6.42M |
Scheduled
|
May 18 - May 20
| ||
Form 4
| -0.25% | -16.42K |
$20.05 | -$329,313.92 | 6.47M |
Scheduled
|
May 13 - May 17
| ||
Form 4
| -1.04% | -68.26K |
$21.04 | -$1,436,555.54 | 6.48M |
Scheduled
|
May 10 - May 12
| ||
Form 4
| -0.16% | -10.17K |
$22.52 | -$229,107.07 | 6.55M |
Scheduled
|
May 5
| ||
Form 4
| -4.77% | -328.52K |
$22.48 | -$7,386,435.35 | 6.56M |
Scheduled
|
Apr 30 - May 4
| ||
Form 4
| -1.85% | -130.14K |
$21.99 | -$2,861,368.42 | 6.89M |
Scheduled
|
Apr 27 - Apr 29
| ||
Form 4
| -0.13% | -8.97K |
$18.97 | -$170,229.38 | 7.02M |
Scheduled
|
Apr 21
| ||
Form 4
| -0.54% | -38.15K |
$19.04 | -$726,550.34 | 7.03M |
Scheduled
|
Apr 16 - Apr 20
| ||
Form 4
| -0.54% | -38.56K |
$20.16 | -$777,359.18 | 7.07M |
Scheduled
|
Apr 13 - Apr 15
| ||
Form 4
| -0.43% | -30.93K |
$21.90 | -$677,357.16 | 7.11M |
Scheduled
|
Apr 9 - Apr 12
| ||
Form 4
|
∞
| 3.9M |
$11.65 | -$6,258.00 | 3.9M |
Feb 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Spring Bank Pharmaceuticals, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
TCR2 THERAPEUTICS INC. No price found
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 3.37M |
$15.00 |
—
| 3.37M |
Feb 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||